KIF26B and breast carcinoma: Furthermore, in breast cancer, the KIF26B phosphorylation level in sites S1006, S1081, S1724, S1772, and S1979 was higher than in normal tissues, and so was site S1953 in LUAD and site S1773 in UCEC (Figures 5(b)–5(g)).